Sanofi's net rises 54% on growth of core businesses

Article Abstract:

Sanofi-Synthelabo SA posted an increase of 54% in its net profits for the 2000 year. The company posted 961 million euros in net earnings for the year.

Sanofi-Synthelabo S.A.

---

Merck's net rises despite lag in sales of arthritis drug

Article Abstract:

Merck and Co. posted an increase of 11% in its 2001 first-quarter net income. The company, which posted disappointing sales of its Vioxx arthritis drug, posted $1.66 billion (1.84 billion euros) in quarterly net income.

United States, Merck & Company Inc.

---

Aventis posts 31% increase in net, raises its targets for full year

Article Abstract:

Aventis S.A. posted an increase of 31% in its net profits for the 2001 second-quarter. The company posted 391 million euros in net profits for its core pharmaceutical business.

Aventis S.A., AVE

Similar abstracts:

• Abstracts: Vivendi Universal posts a 60% rise in net, expects to top latest targets. Vivendi posts a record loss for second year
• Abstracts: Aerospace merger news lifts shares of principals in mostly weak session. DaimlerChrysler launches 6.5 billion euros jumbo issue
• Abstracts: Malaysia's Sime Darby makes 269 million euros offer for Palmco. Softbank venture opens a hub office in Malaysia
• Abstracts: Accident raises safety concerns on Chinese tires: up to 450,000 imports may contain a defect; obstacles to a recall
• Abstracts: L&H's restructuring plan weighs against shareholders (Lernout and Hauspie Speech Products N.V.). Lernout and Hauspie seeks bankruptcy protection

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.